Role of Amniotic Fluid Toxicity in the Pathophysiology of Myelomeningocele: A Narrative Literature Review
- PMID: 39370541
- DOI: 10.1002/pd.6681
Role of Amniotic Fluid Toxicity in the Pathophysiology of Myelomeningocele: A Narrative Literature Review
Abstract
Myelomeningocele is a birth defect whose clinical manifestations are due both to incomplete neural tube closure and the progressive destruction of exposed neuroepithelium during pregnancy. Two hypotheses have been formulated to explain the spinal cord damage in utero: mechanical trauma and chemical factors. The objective of this review was to summarize the current insights about the potential role of amniotic fluid in spinal cord damage in myelomeningocele. Numerous histological and clinical data on animals and humans strongly suggest a progressive degeneration of neural tissue including loss of neural cells, astrogliosis, inflammation, and loss of normal architecture. However, few data have been published about the direct toxicity of amniotic fluid in this neural degeneration, including the potentially toxic effect of meconium. Finally, the chemical and cellular modifications of amniotic fluid composition in myelomeningocele could reflect both the process (toxic effect of meconium) and the consequences of neuroepithelium destruction (release of neural cells). Fetal surgery not only stops the leakage of the cerebrospinal fluid but also reduces the toxic effect of amniotic fluid by restoring the intrauterine environment. Identification of amniotic fluid neurotoxic factors could lead to the development of therapeutic agents designed to protect spinal tissue and improve fetal myelomeningocele outcomes.
Keywords: amniotic fluid; myelomeningocele; neuroepithelium; spinal cord damage; toxicity.
© 2024 The Author(s). Prenatal Diagnosis published by John Wiley & Sons Ltd.
References
-
- L. E. Mitchell, N. S. Adzick, J. Melchionne, P. S. Pasquariello, L. N. Sutton, and A. S. Whitehead, “Spina Bifida,” Lancet (London, England) 364, no. 9448 (2004): 1885–1895, https://doi.org/10.1016/s0140‐6736(04)17445‐x.
-
- N. S. Adzick, “Fetal Myelomeningocele: Natural History, Pathophysiology, and In‐Utero Intervention,” Seminars in Fetal and Neonatal Medicine 15, no. 1 (February 2010): 9–14, https://doi.org/10.1016/j.siny.2009.05.002.
-
- A. J. Copp, P. Stanier, and N. D. E. Greene, “Neural Tube Defects: Recent Advances, Unsolved Questions, and Controversies,” Lancet Neurology 12, no. 8 (August 2013): 799–810, https://doi.org/10.1016/s1474‐4422(13)70110‐8.
-
- D. S. Heffez, J. Aryanpur, G. M. Hutchins, and J. M. Freeman, “The Paralysis Associated With Myelomeningocele: Clinical and Experimental Data Implicating a Preventable Spinal Cord Injury,” Neurosurgery 26, no. 6 (June 1990): 987–992, https://doi.org/10.1227/00006123‐199006000‐00011.
-
- D. Stiefel, A. J. Copp, and M. Meuli, “Fetal Spina Bifida in a Mouse Model: Loss of Neural Function In Utero,” supplement, Journal of Neurosurgery 106, no. S3 (March 2007): 213–221, https://doi.org/10.3171/ped.2007.106.3.213.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources